静脉注射水飞蓟宾联合利巴韦林可快速抑制丙型肝炎病毒血症 - Suppr

Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin.

作者信息

Biermer Michael, Berg Thomas

出版信息

Gastroenterology. 2009 Jul;137(1):390-1. doi: 10.1053/j.gastro.2009.02.087. Epub 2009 May 30.

DOI:10.1053/j.gastro.2009.02.087

PMID:19486953

Abstract

摘要

相似文献

Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin.

Gastroenterology. 2009 Jul;137(1):390-1. doi: 10.1053/j.gastro.2009.02.087. Epub 2009 May 30.

A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.

PLoS One. 2015 Jul 15;10(7):e0133028. doi: 10.1371/journal.pone.0133028. eCollection 2015.

Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

Gastroenterology. 2008 Nov;135(5):1561-7. doi: 10.1053/j.gastro.2008.07.072. Epub 2008 Aug 3.

PEG-IFN and ribavirin re-treatment of HCV-1b cirrhosis non responder to conventional combination therapy.

Dig Liver Dis. 2008 May;40(5):391-2. doi: 10.1016/j.dld.2007.12.010. Epub 2008 Mar 4.

[Predictive value of virological response on sustained virological response in hepatitis C patients].

Zhonghua Gan Zang Bing Za Zhi. 2009 Dec;17(12):944-6.

[Therapy of chronic hepatitis C].

Praxis (Bern 1994). 2014 Apr 9;103(8):423-36. doi: 10.1024/1661-8157/a001618.

Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.

Rev Invest Clin. 2003 Mar-Apr;55(2):138-42.

Response-guided therapy: optimizing treatment now and in the future.

Antivir Ther. 2008;13 Suppl 1:1-2.

[Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].

Eksp Klin Gastroenterol. 2007(4):146-52.

[Therapy of chronic Hepatitis C in 2008].

MMW Fortschr Med. 2008 Mar 27;150(13):31-4. doi: 10.1007/BF03365407.

引用本文的文献

Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review.

Arch Microbiol. 2023 May 30;205(6):252. doi: 10.1007/s00203-023-03590-0.

Mechanistic Insights into the Pharmacological Significance of Silymarin.

Molecules. 2022 Aug 21;27(16):5327. doi: 10.3390/molecules27165327.

Antiviral Activities of Silymarin and Derivatives.

Molecules. 2019 Apr 19;24(8):1552. doi: 10.3390/molecules24081552.

Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.

Molecules. 2017 Oct 21;22(10):1699. doi: 10.3390/molecules22101699.

Impact of oral silymarin on virus- and non-virus-specific T-cell responses in chronic hepatitis C infection.

J Viral Hepat. 2013 Jul;20(7):453-62. doi: 10.1111/jvh.12050. Epub 2013 Apr 12.

Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B.

Hepatology. 2013 Mar;57(3):953-63. doi: 10.1002/hep.26260. Epub 2013 Feb 7.

Understanding silibinin's modes of action against HCV using viral kinetic modeling.

J Hepatol. 2012 May;56(5):1019-1024. doi: 10.1016/j.jhep.2011.12.012. Epub 2012 Jan 13.

Silybin and the liver: from basic research to clinical practice.

World J Gastroenterol. 2011 May 14;17(18):2288-301. doi: 10.3748/wjg.v17.i18.2288.

Silibinin mode of action against hepatitis C virus: a controversy yet to be resolved.

Hepatology. 2011 Aug;54(2):749. doi: 10.1002/hep.24310. Epub 2011 Jun 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献